CAS 328087-38-3

N1-[4-(5-Fluorobenzothiazol-2-yl)-2-methylphenyl]-L-lysinamide dihydrochloride

Description:

N1-[4-(5-Fluorobenzothiazol-2-yl)-2-methylphenyl]-L-lysinamide dihydrochloride is a chemical compound characterized by its complex structure, which includes a lysine derivative linked to a substituted phenyl group. The presence of a fluorobenzothiazole moiety contributes to its potential biological activity, particularly in medicinal chemistry. This compound is typically a white to off-white solid and is soluble in water due to the dihydrochloride salt form, which enhances its solubility and stability. The molecular structure suggests that it may interact with biological targets, making it of interest in pharmaceutical research, particularly in the development of therapeutic agents. Its specific properties, such as melting point, boiling point, and spectral characteristics, would be determined through experimental methods. Safety data and handling precautions are essential, as with any chemical, to ensure proper usage and minimize risks associated with exposure.

Formula: C₂₀H₂₅Cl₂FN₄OS

Synonyms:

• Phortress
• 5F-DF-203-L-lysinamide
• Nsc-710305
• Phortress (hydrochloride)
• (2S)-2,6-Diamino-N-[4-(5-fluoro-2-benzothiazolyl)-2-methylphenyl]hexanamide dihydrochloride

Phortress

CAS: 328087-38-3

Formula: C₂₀H₂₅Cl₂FN₄OS

Purity: 98%

Molecular weight: 459.4081

Ref: IN-DA00CNAQ

Phortress

CAS: 328087-38-3

Phortress

Purity: ≥98%

Molecular weight: 459.41g/mol

Ref: 54-BUP08312

Phortress dihydrochloride

CAS: 328087-38-3

Phortress is a diagnostic agent that belongs to the class of transcription-polymerase chain reaction (PCR) reagents. It is used in the diagnosis of cancers and other diseases by detecting mutations in DNA sequences. Phortress can also be used to detect mutations in RNA sequences, such as messenger RNA (mRNA). The active form of Phortress is hydrolyzed by esterases or glucuronidases, oxidized by cytochrome P450 enzymes, reduced by glutathione reductase, or conjugated with glucuronic acid. Phortress has been shown to inhibit angiogenesis and tumor growth in vitro and in vivo, which may be due to its ability to inhibit the synthesis of proteins required for vascularization and cell proliferation. Phortress contains an anti-angiogenic peptide that inhibits protein synthesis and prevents cells from growing. This peptide targets several steps of the chemical pathway that leads to angiogenesis: it

Formula: C₂₀H₂₃FN₄OS·2HCl

Purity: Min. 95%

Molecular weight: 459.41 g/mol

Ref: 3D-DNA08738

Phortress

CAS: 328087-38-3

Phortress (NSC-710305) is a potent AhR ligand with strong binding affinity, which subsequently triggers the transcription of CYP1A1 and induces antitumor

Formula: C₂₀H₂₅Cl₂FN₄OS

Purity: 99.89%

Color and Shape: Solid

Molecular weight: 459.41

Ref: TM-T23151